Skip to content

Compare the effects of Metformin and Exenatide on pregnancy rate and outcomes in overweight or obese PCOS women

Compare the effects of Metformin and Exenatide on pregnancy rate and outcomes in overweight or obese PCOS women

Status
Active, not recruiting
Phases
Phase 4
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2100041813
Enrollment
Unknown
Registered
2021-01-06
Start date
2019-01-01
Completion date
Unknown
Last updated
2021-03-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Polycystic ovarian syndrome

Interventions

MET group:metformin and lifestyle intervention
EXE group:exenatide and lifestyle intervention

Sponsors

The Third Affiliated Hospital of Guangzhou Medical University
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
20 Years to 40 Years

Inclusion criteria

Inclusion criteria: 1. Patients who meet the diagnostic criteria of PCOS according to the revised diagnostic criteria of Rotterdam working group of American Society of reproductive medicine (ASRM); 2. Patients with body mass index >= 24kg / m2; 3. Subjects aged 20-40 years old; 4. Subjects who planned to be pregnant and had a history of infertility for 2 years; 5. At least one side of fallopian tube was unobstructed in the subjects without uterine malformation; 6. Subjects whose husbands had no history of infertility.

Exclusion criteria

Exclusion criteria: 1. Patients with type 1 or type 2 diabetes mellitus; 2. Patients with previous history of autoimmune system or malignant tumor; 3. Patients with severe history of heart, lung, kidney and liver; 4. Other endocrine diseases leading to infertility, such as hyperprolactinemia and congenital adrenal hyperplasia; 5. Subjects who took drugs known to affect reproductive function or metabolic system in recent 90 days, or took statins; 6. Subjects without other reproductive system diseases.

Design outcomes

Primary

MeasureTime frame
spontaneous pregnancy rate;

Secondary

MeasureTime frame
total pregnancy rate;miscarriage rate;live brith rate;preterm rate;GDM incidence;gestational hypertension incidence;metabolism biomarkers;

Countries

China

Contacts

Public ContactYing Zhang

The Third Affiliated Hospital of Guangzhou Medical University

zhangying30412@163.com+86 18928916685

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026